ATAI Life Sciences N.V (NASDAQ:ATAI) currently has a daily average trading volume of 1.87M but it saw 2239638 shares traded in last market. With a market cap of 404.68M USD, the company’s current market price of $2.02 came rising about 5.76 while comparing to the previous closing price of $1.91. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.57 and as low as $1.03.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which reiterated the stock as “Buy” in its note to investors issued on November 18, 2024, recommending a price target of between $15 and $10 for it. Maxim Group upgraded its recommendation for the stock as a “Buy” from “Hold” on April 03, 2024 while assigning a price target of $6. Loop Capital issued its recommendations for the stock as it initiated the price target for the stock is $18.
Over the week, ATAI’s stock price is moving 23.93% up while it is 32.89% when we observe its performance for the past one month. Year-to-date it is 51.88% up and over the past year, the stock is showing an upside performance of 16.76%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.11 while estimate for next year EPS is -0.5.
Currently, ATAI Life Sciences N.V’s total number of outstanding shares is 199.78M with 8.46% of that held by the insiders while 32.69% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -77.36% and return on equity (ROE) at -62.43%. Stock’s beta reads 1.33. Stock has a price to book (P/B) ratio of 2.65 while price to sale or P/S ratio amounts to 1226.30. Its return on asset (ROA) is -50.86% on average.
